Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
MedTech
Roche, Eli Lilly net FDA approval for Alzheimer’s biomarker test
Roche and Eli Lilly have secured FDA clearance for their latest Alzheimer’s disease diagnostic.
Ben Adams
Aug 24, 2026 8:15am
Lilly pens deal with Gateway Labs resident for RNA vax platform
Aug 20, 2026 10:45am
Lilly pens $370M deal with OmniAb for ion channel collab
Aug 17, 2026 7:43am
PTC bets $211M on ‘special opportunity’ to enter Fabry market
Aug 13, 2026 8:15am
Lilly drops another gene therapy trial from $1B Prevail buyout
Aug 5, 2026 9:10am
Eli Lilly takes top spot on new biopharma productivity ranking
Jul 28, 2026 1:00pm
